174 related articles for article (PubMed ID: 5488234)
1. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
Becker-Christensen F; Bang HO; Ditzel J
Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
[No Abstract] [Full Text] [Related]
2. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
Becker-Christensen F; Bang HO; Ditzel J
Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
[No Abstract] [Full Text] [Related]
3. [Controllable hypertension therapy with Tadip].
Schütz E
Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
[No Abstract] [Full Text] [Related]
4. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
Seedat YK; Vawda EI; Mitha S; Ramasar R
S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
[No Abstract] [Full Text] [Related]
5. [Use of St 155 in chronic renal insufficiency with arterial hypertension].
Previgliano H; Challu A; Junemann A; Rodano J; Marchand M; Taype E; Gonzalez Ortiz R; Lammirato G; Rodrigues C; Gallardo R; De Felipe C; De la Riestra N
Prensa Med Argent; 1971 Jul; 58(22):1117-9. PubMed ID: 5097755
[No Abstract] [Full Text] [Related]
6. [Controlled long-term study in senile hypertension].
Bergener M; Mittelstaedt A
Arzneimittelforschung; 1970 Oct; 20(10):1542-5. PubMed ID: 5536421
[No Abstract] [Full Text] [Related]
7. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
Krämer D; Krause W; Renner H
Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
[No Abstract] [Full Text] [Related]
8. [Treatment of hypertension with a new kind of drug combination].
Emich R; Roiko G
Wien Med Wochenschr; 1968 Oct; 118(40):822-5. PubMed ID: 5710853
[No Abstract] [Full Text] [Related]
9. [A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension].
Guillén Llera F; Reuss JM; Sagués F; Tobares N
Rev Clin Esp; 1991 Dec; 189(9):412-5. PubMed ID: 1792369
[TBL] [Abstract][Full Text] [Related]
10. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
Meine H
Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
[TBL] [Abstract][Full Text] [Related]
11. [100 hypertensive patients treated with methyldopa. Therapeutical experience].
Pellanda RJ; Pastoriza FE; Altamira J
Prensa Med Argent; 1968 Apr; 55(6):292-304. PubMed ID: 5740843
[No Abstract] [Full Text] [Related]
12. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
13. Methyldopa: single daily dose versus multiple daily dose.
Yang C; Gurwich E; Kanada S; Nascimento L
Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
[TBL] [Abstract][Full Text] [Related]
14. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
Lotti G; Gianrossi R
Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
[TBL] [Abstract][Full Text] [Related]
15. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O; Berrou JP; Negre-Pages L; Goch JH; Nádházi Z; Petrella R; Sedefdjian A; Sévenier F; Shlyakhto EV; Pathak A
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].
Seige K; Preuss EG; Mörl H; Köhler I; Lantzsch W
Med Welt; 1969 Mar; 10():520-6. PubMed ID: 5772239
[No Abstract] [Full Text] [Related]
18. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
Karachalios GN
Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of renal hypertension with alpha-methylodopa (Presinol) and Cyclazenin (Leron)].
Sarre H; Oechslen D
Med Klin; 1967 Apr; 62(14):561-5. PubMed ID: 5592469
[No Abstract] [Full Text] [Related]
20. Methyldopa supplement for resistant essential hypertension: a prospective randomized placebo control crossover study.
Sermswan A; Archawarak N
J Med Assoc Thai; 2003 Dec; 86(12):1156-61. PubMed ID: 14971524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
